We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+20.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$176M
AUM Growth
+$107M
Cap. Flow
+$103M
Cap. Flow %
58.75%
Top 10 Hldgs %
4.24%
Holding
1,234
New
413
Increased
180
Reduced
1
Closed
640

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$895K
2
PLAB icon
Photronics
PLAB
+$774K
3
EW icon
Edwards Lifesciences
EW
+$755K
4
MMS icon
Maximus
MMS
+$754K
5
TTEK icon
Tetra Tech
TTEK
+$745K

Top Sells

Rank Stock Value
1
DK icon
Delek US
DK
+$197K
2
CSGP icon
CoStar Group
CSGP
+$197K
3
VIST icon
Vista Energy
VIST
+$197K
4
SKX
Skechers
SKX
+$196K
5
ALRS icon
Alerus Financial
ALRS
+$195K

Sector Composition

Rank Sector Weight
1 Healthcare 19.45%
2 Technology 17.59%
3 Industrials 17.43%
4 Consumer Discretionary 12.31%
5 Financials 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOC icon
376
Northrop Grumman
NOC
$77B
$234K 0.13%
443
+146
+49% +$71.5K
SNOW icon
377
Snowflake
SNOW
$92.9B
$234K 0.13%
2,035
+854
+72% +$105K
LSCC icon
378
Lattice Semiconductor
LSCC
$17.6B
$233K 0.13%
4,394
+4,053
+1,189% +$208K
AME icon
379
Ametek
AME
$55.5B
$233K 0.13%
+1,356
New +$226K
GRNT icon
380
Granite Ridge Resources
GRNT
$640M
$232K 0.13%
+39,086
New +$250K
RDFN
381
DELISTED
Redfin
RDFN
$231K 0.13%
+18,457
New +$170K
CNXC icon
382
Concentrix
CNXC
$1.36B
$231K 0.13%
+4,508
New +$302K
CBSH icon
383
Commerce Bancshares
CBSH
$8.5B
$231K 0.13%
+4,288
New +$238K
JNJ icon
384
Johnson & Johnson
JNJ
$635B
$231K 0.13%
+1,424
New +$227K
IPGP icon
385
IPG Photonics
IPGP
$3.89B
$228K 0.13%
+3,071
New +$230K
GPCR icon
386
Structure Therapeutics
GPCR
$3.49B
$227K 0.13%
5,165
+1,480
+40% +$57.2K
JELD icon
387
JELD-WEN Holding
JELD
$94.8M
$227K 0.13%
14,333
+6,273
+78% +$92.1K
SBCF icon
388
Seacoast Banking Corp of Florida
SBCF
$3.26B
$226K 0.13%
+8,469
New +$224K
ASPN icon
389
Aspen Aerogels
ASPN
$387M
$225K 0.13%
+8,141
New +$204K
CRL icon
390
Charles River Laboratories
CRL
$10.9B
$225K 0.13%
+1,144
New +$238K
CODI icon
391
Compass Diversified
CODI
$755M
$225K 0.13%
10,178
+1,782
+21% +$38.8K
STEP icon
392
StepStone Group
STEP
$3.48B
$225K 0.13%
3,955
+685
+21% +$34.9K
TAK icon
393
Takeda Pharmaceutical
TAK
$55.1B
$225K 0.13%
+15,804
New +$224K
CAR icon
394
Avis
CAR
$5.63B
$225K 0.13%
2,565
+1,038
+68% +$93.6K
YMAB
395
DELISTED
Y-mAbs Therapeutics
YMAB
$224K 0.13%
17,071
+10,919
+177% +$138K
MTZ icon
396
MasTec
MTZ
$26.7B
$224K 0.13%
+1,823
New +$199K
CNXN icon
397
PC Connection
CNXN
$2.05B
$224K 0.13%
2,972
+616
+26% +$42.8K
GERN icon
398
Geron
GERN
$911M
$224K 0.13%
+49,263
New +$224K
SNEX icon
399
StoneX
SNEX
$8.83B
$223K 0.13%
9,173
+3,199
+54% +$75.4K
TRS icon
400
TriMas Corp
TRS
$1.43B
$222K 0.13%
8,710
+1,157
+15% +$29K

Similar funds

EntryPoint Capital's Q3 2024 Portfolio in Review

As of Q3 2024, EntryPoint Capital held 1,234 positions worth $176M, up 157% from $68.4M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

EntryPoint Capital deployed $103M of net new capital in Q3 2024, opening 413 new positions and adding to 180 existing holdings. Its largest new stake was Guardant Health: 31,633 shares worth $726K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iRadimed, an estimated $8.4K trimmed.

  • EntryPoint Capital's largest Q3 2024 buy was Guardant Health: 31,633 shares worth $726K.
  • EntryPoint Capital added most to Edwards Lifesciences in Q3 2024, an estimated $755K increase.
  • EntryPoint Capital's biggest Q3 2024 reduction was iRadimed, cutting an estimated $8.4K.
  • EntryPoint Capital fully exited Delek US in Q3 2024, selling an estimated $197K.
  • EntryPoint Capital's ten largest holdings make up 4.2% of its $176M portfolio in Q3 2024.
  • EntryPoint Capital opened 413 new positions and closed 640 in Q3 2024.
  • EntryPoint Capital's portfolio value rose 157% quarter-over-quarter to $176M.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.